Skip to content
Adrienne Monson – Lifestyle
Author:
AEON Biopharma Inc
AEON Biopharma Announces FDA Feedback Following BPD Type 2a Meeting for the ABP-450 Biosimilar Program
March 25, 2026
AEON Biopharma Appoints John Bencich as Chief Financial Officer
March 9, 2026
←
Previous Page
1
2